152607-29-9

Upstream product

• 111742-99-5 hexahydro-7-phenyl-1H-azepin-2-one 
• 111742-93-9 6-[(E)-Hydroxyimino]-6-phenyl-hexanoic acid ethyl ester 
• 4248-25-3 ethyl 6-oxo-6-phenylhexanoate 
• 111742-98-4 6-Amino-6-phenyl-hexanoic acid 2,5-dioxo-pyrrolidin-1-yl ester; hydrochloride 
• 111742-97-3 6-tert-Butoxycarbonylamino-6-phenyl-hexanoic acid 2,5-dioxo-pyrrolidin-1-yl ester 
• 111742-96-2 6-tert-Butoxycarbonylamino-6-phenyl-hexanoic acid 

Downstream Products

• 111820-55-4 (S)-2-((3S,7R)-1-Carboxymethyl-2-oxo-7-phenyl-azepan-3-ylamino)-4-phenyl-butyric acid ethyl ester; hydrochloride 
• 111820-56-5 (S)-2-((3S,7S)-1-Carboxymethyl-2-oxo-7-phenyl-azepan-3-ylamino)-4-phenyl-butyric acid ethyl ester; hydrochloride 
• 111743-14-7 ((3R,7R)-3-Amino-2-oxo-7-phenyl-azepan-1-yl)-acetic acid tert-butyl ester 
• 111743-13-6 ((3S,7R)-3-Amino-2-oxo-7-phenyl-azepan-1-yl)-acetic acid tert-butyl ester 
• 111743-11-4 ((3R,7R)-3-Azido-2-oxo-7-phenyl-azepan-1-yl)-acetic acid tert-butyl ester 
• 111820-51-0 (S)-2-((3S,7R)-1-Carboxymethyl-2-oxo-7-phenyl-azepan-3-ylamino)-4-phenyl-butyric acid 
• 81938-91-2 (S)-2-((3S,7S)-1-Carboxymethyl-2-oxo-7-phenyl-azepan-3-ylamino)-4-phenyl-butyric acid 
• 111820-60-1 (S)-2-((3R,7R)-1-tert-Butoxycarbonylmethyl-2-oxo-7-phenyl-azepan-3-ylamino)-4-phenyl-butyric acid ethyl ester 
• 111820-52-1 (S)-2-((3S,7R)-1-tert-Butoxycarbonylmethyl-2-oxo-7-phenyl-azepan-3-ylamino)-4-phenyl-butyric acid ethyl ester 
• 111820-59-8 (S)-2-((3R,7S)-1-tert-Butoxycarbonylmethyl-2-oxo-7-phenyl-azepan-3-ylamino)-4-phenyl-butyric acid ethyl ester 
• 111820-53-2 (S)-2-((3S,7S)-1-tert-Butoxycarbonylmethyl-2-oxo-7-phenyl-azepan-3-ylamino)-4-phenyl-butyric acid ethyl ester 
• 111743-07-8 rac-(3R,7S)-3-azido-7-phenylazepan-2-one 
• 111743-08-9 rac-(3S,7S)-3-azido-7-phenylazepan-2-one 

Relevant academic research and scientific papers

Cgrp Receptor Antagonists

Compounds of Formula I: and Formula II: (where variables R1, R2, R3, R4, A, B, D, G, J, Q, T, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or pr

LACTAMS AND BICYCLIC LACTAMS USEFUL AS CHOLECYSTOKININ ANTAGONISTS

This invention relates to lactams, bicyclic lactams and related compounds which are useful as cholecystokinin antagonists.

Angiotensin-converting enzyme inhibitors. 2. Perhydroazepin-2-one derivatives

α-[(3S)-3-[[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-6 or 7-phenylperhydroazepin-1-yl]acetic acids (monoester monoacids) and their dicarboxylic acids were synthesized, and their angiotensin-converting enzyme (ACE) inhibitory activities were eval